Work

Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignancies.

Year: 2003

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Charlotte Rees, P Beale, Jose Manuel Trigo, Fraser Mitchell, Anne Jackman, Robert Smith, Edwin Douglass, Ian Judson

Institution: Institute of Cancer Research

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2149773770

FWCI: 1.164

Cites: 13

Cited by: 13

Related to: 10